Intravenous Fluid Transfer Drug Devices Market Set to Reach $9.96 Billion by 2029 with 6.1% Yearly Growth

What combination of drivers is leading to accelerated growth in the intravenous fluid transfer drug devices market?
The escalating rate of hospital admissions is anticipated to foster the expansion of the market for intravenous fluid transfer drug devices. The growth in hospitalization rates stems from factors such as an aging demographic, chronic diseases, improved diagnostic techniques, enhanced healthcare access, diseases tied to lifestyle choices, and progress in medical technology. In a hospital setting, fluid transfer systems play a crucial role in administering fluids and medications with accuracy and control directly into a patient's bloodstream. For example, a report by the American Hospital Association (AHA), a healthcare trade organization in the U.S. that represents hospitals and health networks, stated in May 2023 that the total hospitalizations in all U.S. hospitals had risen to 34,011,386 from a previous 33,356,853 in 2022. Consequently, the surge in hospital admission rates will contribute to the growth of the intravenous fluid transfer drug device market.

Get Your Intravenous Fluid Transfer Drug Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

What is the projected compound annual growth rate (CAGR) of the intravenous fluid transfer drug devices market from 2025 to 2034, and what factors influence it?
The market size for devices involved in the transfer of drugs via intravenous fluid has seen substantial growth in the past years. The market, initially valued at $7.38 billion in 2024, is projected to expand to $7.85 billion in 2025, showing a compound annual growth rate (CAGR) of 6.4%. The historic growth can be associated with the rise in demand for competent medical supplies, development of healthcare infrastructure, an increase in surgical procedures requiring intravenous support, policy shifts, further advancement in healthcare infrastructure and the introduction of new drugs needing precise administration.

The market for intravenous fluid transfer drug devices is forecasted to experience a robust increase in the upcoming years, set to reach $9.96 billion in 2029 with a compound annual growth rate (CAGR) of 6.1%. The anticipated growth during this predictive period is driven by factors such as the escalating need for portable devices, amplified investments in high-end medical devices, increasing demand for economical healthcare solutions, and the development of non-hospital treatment environments. During the forecast period, the primary trends are likely to include the incorporation of cutting-edge technologies, the utilization of automatic IV fluid transfer systems, improvements in safety features to minimize medication faults, and the employing of devices that are compatible with remote monitoring systems.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp

How are the latest trends influencing the growth of the intravenous fluid transfer drug devices market?
Leading firms in the intravenous fluid transfer drug device market are focusing on creating modular and all-inclusive infusion systems with capabilities like auto-identification to increase precision, enhance patient safety, and simplify fluid and medication management. The auto-identification feature in these systems verifies and matches the correct medication to the right patient via barcode scanning or RFID technology. For example, Becton, Dickinson and Company, a medical device corporation based in the US, obtained FDA 510(k) clearance for its revamped BD Alaris Infusion System in July 2023. The updated system includes new hardware components for its Point-of-Care Unit (PCU), such as large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitors, and auto-identification modules. In addition, the system introduces a new software version that offers enhanced cybersecurity and interoperability features that enable easy integration with commonly used electronic medical record (EMR) systems, promoting smart and connected healthcare solutions.

What are the major segments of the intravenous fluid transfer drug devices market and their role in driving growth?
The intravenous fluid transfer drug devicesmarket covered in this report is segmented -

1) By Type: Infusion Bags, Infusion Devices, Other Types
2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications
3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors

Subsegments:
1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags
2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices
3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19535

Which regions are key players in the growth of the intravenous fluid transfer drug devices market?
North America was the largest region in the intravenous fluid transfer drug devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the intravenous fluid transfer drug devices market?
Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., 3M Company, Medtronic plc, Becton, Dickinson and Company, Baxter International Inc., B. Braun Holding GmbH & Co. KG, Fresenius Kabi AG, Mindray Medical International Limited, Nipro Corporation, Moog Inc., West Pharmaceutical Services Inc., ICU Medical Inc., Insulet Corporation, Merit Medical Systems Inc., Avanos Medical Inc., Vygon SAS, NxStage Medical Inc., AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Zyno Medical LLC, Sippex, Arcomed AG

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19535&type=smp

What Is Covered In The Intravenous Fluid Transfer Drug Devices Global Market Report?

•Market Size Forecast: Examine the intravenous fluid transfer drug devices market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the intravenous fluid transfer drug devices market for a structured understanding.
•Key Players Overview: Analyze major players in the intravenous fluid transfer drug devices market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the intravenous fluid transfer drug devices market.
•Segment Contributions: Evaluate how different segments drive overall growth in the intravenous fluid transfer drug devices market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the intravenous fluid transfer drug devices market.
•Industry Challenges: Identify potential risks and obstacles affecting the intravenous fluid transfer drug devices market.
•Competitive Landscape: Review strategic developments in the intravenous fluid transfer drug devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.